Factors associated with treatment initiation for psychiatric and substance use disorders among persons with HIV

Psychiatric Services

Volumn 64, Issue 8, 2013, Pages 745-753

  Satre, Derek D ^a,b   DeLorenze, Gerald N ^a   Quesenberry Jr , Charles P ^a   Tsai, Ailin ^a   Weisner, Constance ^a,b  

^a DIVISION OF RESEARCH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AMPHETAMINE; CANNABIS; COCAINE; OPIATE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ALCOHOL ABUSE; ARTICLE; BIPOLAR DISORDER; CANNABIS ADDICTION; COHORT ANALYSIS; DEMOGRAPHY; DRUG DEPENDENCE TREATMENT; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTEGRATED HEALTH CARE SYSTEM; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MEN WHO HAVE SEX WITH MEN; MENTAL DISEASE; MULTIPLE DRUG ABUSE; NEUROSIS; OUTCOME ASSESSMENT; PATIENT CARE; PSYCHIATRIC DIAGNOSIS; PSYCHIATRIC TREATMENT; REFERENCE DATABASE; REGISTER; RETROSPECTIVE STUDY; RISK FACTOR; SCHIZOPHRENIA; SEXUAL TRANSMISSION; SOCIAL STATUS; SUBSTANCE ABUSE; UNITED STATES;

ADULT; CALIFORNIA; COMORBIDITY; DELIVERY OF HEALTH CARE, INTEGRATED; FEMALE; HEALTH SERVICES; HIV INFECTIONS; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; RETROSPECTIVE STUDIES; SUBSTANCE-RELATED DISORDERS;

EID: 84883136605     PISSN: 10752730     EISSN: 15579700     Source Type: Journal    
DOI: 10.1176/appi.ps.201200064     Document Type: Article

References (58)

1. Lopes M, Olfson M, Rabkin J, et al: Gender, HIV status, and psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Clinical Psychiatry 73:384-391, 2012
2. Nurutdinova D, Chrusciel T, Zeringue A, et al: Mental health disorders and the risk of AIDS-defining illness and death in HIVinfected veterans. AIDS 26:229-234, 2012
3. Pence BW, Miller WC, Whetten K, et al: Prevalence of DSM-IV-defined mood, anxiety, and substance use disorders in an HIV clinic in the Southeastern United States. Journal of Acquired Immune Deficiency Syndromes 42:298-306, 2006
4. Bing EG, Burnam MA, Longshore D, et al: Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Archives of General Psychiatry 58:721-728, 2001
5. DeLorenze GN, Weisner C, Tsai AL, et al: Excess mortality among HIV-infected patients diagnosed with substance use dependence or abuse receiving care in a fully integrated medical care program. Alcoholism, Clinical and Experimental Research 35: 203-210, 2011
6. Altice FL, Kamarulzaman A, Soriano VV, et al: Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. Lancet 376:367-387, 2010
7. Robinson-Papp J, Gelman BB, Grant I, et al: Substance abuse increases the risk of neuropathy in an HIV-infected cohort. Muscle and Nerve 45:471-476, 2012
8. Pence BW: The impact of mental health and traumatic life experiences on antiretroviral treatment outcomes for people living with HIV/AIDS. Journal of Antimicrobial Chemotherapy 63:636-640, 2009
9. Kacanek D, Jacobson DL, Spiegelman D, et al: Incident depression symptoms are associated with poorer HAART adherence: a longitudinal analysis from the Nutrition for Healthy Living study. Journal of Acquired Immune Deficiency Syndromes 53:266-272, 2010
10. Carrico AW, Riley ED, Johnson MO, et al: Psychiatric risk factors for HIV disease progression: the role of inconsistent patterns of antiretroviral therapy utilization. Journal of Acquired Immune Deficiency Syndromes 56:146-150, 2011
11. Gonzalez A, Barinas J, O'Cleirigh C: Substance use: impact on adherence and HIV medical treatment. Current HIV/AIDS Reports 8:223-234, 2011
12. Antelman G, Kaaya S, Wei R, et al: Depressive symptoms increase risk of HIV disease progression and mortality among women in Tanzania. Journal of Acquired Immune Deficiency Syndromes 44:470-477, 2007
13. Ickovics JR, Hamburger ME, Vlahov D, et al: Mortality, CD4 cell count decline, and depressive symptoms among HIVseropositive women: longitudinal analysis from the HIV Epidemiology Research Study. JAMA 285:1466-1474, 2001
14. Hessol NA, Kalinowski A, Benning L, et al: Mortality among participants in the Multicenter AIDS Cohort Study and the Women's Interagency HIV Study. Clinical Infectious Diseases 44:287-294, 2007
15. French AL, Gawel SH, Hershow R, et al: Trends in mortality and causes of death among women with HIV in the United States: a 10-year study. Journal of Acquired Immune Deficiency Syndromes 51:399-406, 2009
16. Palepu A, Horton NJ, Tibbetts N, et al: Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems: the impact of substance abuse treatment. Addiction 99:361-368, 2004
17. Carrico AW, Bangsberg DR, Weiser SD, et al: Psychiatric correlates of HAART utilization and viral load among HIVpositive impoverished persons. AIDS 25: 1113-1118, 2011
18. Yun LW, Maravi M, Kobayashi JS, et al: Antidepressant treatment improves adherence to antiretroviral therapy among depressed HIV-infected patients. Journal of Acquired Immune Deficiency Syndromes 38:432-438, 2005
19. Coleman SM, Blashill AJ, Gandhi RT, et al: Impact of integrated and measurement-based depression care: clinical experience in an HIV clinic. Psychosomatics 53:51-57, 2012
20. Hoang T, Goetz MB, Yano EM, et al: The impact of integrated HIV care on patient health outcomes. Medical Care 47:560-567, 2009
21. DeLorenze GN, Satre DD, Quesenberry CP, et al: Mortality after diagnosis of psychiatric disorders and co-occurring substance use disorders among HIV-infected patients. AIDS Patient Care and STDs 24: 705-712, 2010
22. Soller M, Kharrazi N, Prentiss D, et al: Utilization of psychiatric services among low-income HIV-infected patients with psychiatric comorbidity. AIDS Care 23: 1351-1359, 2011
23. Taylor SL, Burnam MA, Sherbourne C, et al: The relationship between type of mental health provider and met and unmet mental health needs in a nationally representative sample of HIV-positive patients. Journal of Behavioral Health Services and Research 31:149-163, 2004
24. Weaver MR, Conover CJ, Proescholdbell RJ, et al: Utilization of mental health and substance abuse care for people living with HIV/AIDS, chronic mental illness, and substance abuse disorders. Journal of Acquired Immune Deficiency Syndromes 47: 449-458, 2008
25. Andersen R, Newman JF: Societal and individual determinants of medical care utilization in the United States. Milbank Memorial Fund Quarterly: Health and Society 51:95-124, 1973
26. Satre DD, Knight BG, Dickson-Fuhrmann E, et al: Predictors of alcohol-treatment seeking in a sample of older veterans in the GET SMART program. Journal of the American Geriatrics Society 51:380-386, 2003
27. Dhingra SS, Zack M, Strine T, et al: Determining prevalence and correlates of psychiatric treatment with Andersen's behavioral model of health services use. Psychiatric Services 61:524-528, 2010
28. Bruwer B, Sorsdahl K, Harrison J, et al: Barriers to mental health care and predictors of treatment dropout in the South African Stress and Health Study. Psychiatric Services 62:774-781, 2011
29. Carragher N, Adamson G, Bunting B, et al: Treatment-seeking behaviours for depression in the general population: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Affective Disorders 121:59-67, 2010
30. Wang PS, Lane M, Olfson M, et al: Twelve-month use of mental health services in the United States: results from the National Comorbidity Survey Replication. Archives of General Psychiatry 62:629-640, 2005
31. Weisner C, Matzger H, Tam T, et al: Who goes to alcohol and drug treatment? Understanding utilization within the context of insurance. Journal of Studies on Alcohol 63:673-682, 2002
32. Orwat J, Saitz R, Tompkins CP, et al: Substance abuse treatment utilization among adults living with HIV/AIDS and alcohol or drug problems. Journal of Substance Abuse Treatment 41:233-242, 2011
33. Burnam MA, Bing EG, Morton SC, et al: Use of mental health and substance abuse treatment services among adults with HIV in the United States. Archives of General Psychiatry 58:729-736, 2001
34. Himelhoch S, Josephs JS, Chander G, et al; HIV Research Network: use of outpatient mental health services and psychotropic medications among HIV-infected patients in a multisite, multistate study. General Hospital Psychiatry 31:538-545, 2009
35. Pisu M, Cloud G, Austin S, et al: Substance abuse treatment in an urban HIV clinic: who enrolls and what are the benefits? AIDS Care 22:348-354, 2010
36. Krieger N: Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. American Journal of Public Health 82:703-710, 1992
37. Weisner C, Mertens J, Parthasarathy S, et al: Integrating primary medical care with addiction treatment: a randomized controlled trial. JAMA 286:1715-1723, 2001
38. Brown C, Barner J, Bohman T, et al: A multivariate test of an expanded Andersen Health Care utilization model for complementary and alternative medicine (CAM) use in African Americans. Journal of Alternative and Complementary Medicine 15:911-919, 2009
39. Yoon J, Bernell SL: The role of adverse physical health events on the utilization of mental health services. Health Services Research 48:175-194, 2013
40. Chi FW, Satre DD, Weisner C: Chemical dependency patients with cooccurring psychiatric diagnoses: service patterns and 1-year outcomes. Alcoholism, Clinical and Experimental Research 30:851-859, 2006
41. Mertens JR, Lu YW, Parthasarathy S, et al: Medical and psychiatric conditions of alcohol and drug treatment patients in an HMO: comparison with matched controls. Archives of Internal Medicine 163:2511- 2517, 2003
42. Garnick DW, Lee MT, Chalk M, et al: Establishing the feasibility of performance measures for alcohol and other drugs. Journal of Substance Abuse Treatment 23:375-385, 2002
43. Summary table of measures, product lines and changes: HEDIS 2013 measures. Washington, DC, National Committee for Quality Assurance, 2012. Available at www.ncqa.org/Portals/0/HEDISQM/HEDIS%202011/SUMMARY- TABLE-OF-MEASURES-for-HEDIS-2012.pdf.
44. Andersen RM: Revisiting the behavioral model and access to medical care: does it matter? Journal of Health and Social Behavior 36:1-10, 1995
45. Hulka BS, Wheat JR: Patterns of utilization: the patient perspective. Medical Care 23:438-460, 1985
46. Mojtabai R, Crum RM: Perceived unmet need for alcohol and drug use treatments and future use of services: results from a longitudinal study. Drug and Alcohol Dependence 127:59-64, 2012
47. McCabe SE, West BT, Hughes TL, et al: Sexual orientation and substance abuse treatment utilization in the United States: results from a national survey. Journal of Substance Abuse Treatment 44:4-12, 2012
48. Green-Hennessy S: Factors associated with receipt of behavioral health services among persons with substance dependence. Psychiatric Services 53:1592-1598, 2002
49. Hennessy KD, Green-Hennessy S,Marshall CC: Reported mental health specialty care in the 2010 HealthStyles Survey. Psychiatric Services 63:306, 2012
50. Kessler RC, Demler O, Frank RG, et al: Prevalence and treatment of mental disorders, 1990 to 2003. New England Journal of Medicine 352:2515-2523, 2005
51. Mojtabai R: Unmet need for treatment of major depression in the United States. Psychiatric Services 60:297-305, 2009
52. Hooshyar D, Goulet J, Chwastiak L, et al: Time to depression treatment in primary care among HIV-infected and uninfected veterans. Journal of General Internal Medicine 25:656-662, 2010
53. Wang PS, Demler O, Olfson M, et al: Changing profiles of service sectors used for mental health care in the United States. American Journal of Psychiatry 163:1187- 1198, 2006
54. Mertens JR, Chi FW, Sterling S, et al. Alcohol SBIRT implementation in adult primary care: preliminary results from an integrated health care delivery system. Presented at INEBRIA, Boston, Sept 21-23, 2011
55. Satre D, DeLorenze GN, Quesenberry CP Jr, et al: Integrating substance use and psychiatric disorder treatment for patients with HIV. Presented at annual Research Society on Alcoholism Scientific Meeting, San Francisco, June 23-27, 2012
56. Unützer J, Katon W, Callahan CM, et al: Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial. JAMA 288: 2836-2845, 2002
57. Hunkeler EM, Hargreaves WA, Fireman B, et al: A Web-delivered care management and patient self-management program for recurrent depression: a randomized trial. Psychiatric Services 63:1063-1071, 2012
58. Satre DD, Campbell CI, Gordon NS, et al: Ethnic disparities in accessing treatment for depression and substance use disorders in an integrated health plan. International Journal of Psychiatry in Medicine 40: 57-76, 2010